Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Awareness Campaigns Launched by Central Authorities to Underpin Anticancer Drugs Market GrowthThe anticancer drugs market is projected to reach ~US$ 156 Bn by 2025.
By: Fact.MR All-in-all, market players can look at healthy growth of the landscape, with a CAGR of ~7% during the forecast period (2020-2025), as estimated by an exclusive study published by Fact.MR. Key Takeaways of Anticancer Drugs Market Study • Governments and central authorities, especially in developed regions, are supporting research & development activities undertaken by players in the anticancer drugs market, which will strengthen the pipeline for anticancer drugs. For instance, the U.S. government allocates a separate budget for the National Cancer Institute (NCI) - an institute that conducts clinical trials on cancer patients. • Growing awareness regarding cancer prevention and treatment, on the back of campaigns run by government organizations and NGOs across the world, is projected to encourage people to undergo screening tests. • Some patients show reluctance towards anticancer drugs, on account of the underlying side-effects associated with their long-term consumption, which is likely to impede the sales prospects of players in the anticancer drugs market during the forecast period. • Sales of anticancer drugs for the treatment of breast cancer, which is one of the most common cancer types across the world, will remain high during the forecast period. Awareness programs conducted to spread information about breast cancer are likely to create a large patient pool for the anticancer drugs market during the forecast period. Read Report- https://www.factmr.com/ A senior market research analyst at Fact.MR opines that, "A shift away from conventional therapies towards targeted therapies will remain crucial for the growth of the anticancer drugs market during the forecast period. In the future, as advanced therapeutics are introduced by market players, the preference for therapies with the least side-effects will be high." Prominent Players Seek Market Growth through Co-developing Agreements The anticancer drugs market is a consolidated landscape, with F. Hoffmann-La Roche Ltd, Eli Lily and Company, Novartis AG, Pfizer, Inc., and CELGENE CORPORATION holding a significant chunk of the market share. PR Source- https://www.factmr.com/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|